Literature DB >> 8130707

Opiate users and the first years after treatment: outcome analysis of the proportion of follow up time spent in abstinence.

M Sheehan1, E Oppenheimer, C Taylor.   

Abstract

This second report on a follow-up study of drug users focuses on changes that occurred on a number of variables between intake and follow-up and during the follow-up period. The length of abstinence from opiates was considered as a proportion of the total follow-up period. Overall there was a reduction in opiate use, in injecting and sharing equipment at follow-up. There had been, however, a high level of these risky activities during the follow-up period. Sustained abstinence from opiates was associated with increased employment, enhanced social stability and mental health. Intake drug use was strongly related to follow-up drug status. In particular, those who were injectors of multiple drugs at intake were far less likely to be long term opiate abstainers at follow-up than those who were not injectors at intake or injectors of opiates only.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8130707     DOI: 10.1111/j.1360-0443.1993.tb02043.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  3 in total

Review 1.  Quality of life as an outcome of opioid use disorder treatment: A systematic review.

Authors:  Jeremy W Bray; Brandon Aden; Ashley A Eggman; Leah Hellerstein; Eve Wittenberg; Bohdan Nosyk; Judy C Stribling; Bruce R Schackman
Journal:  J Subst Abuse Treat       Date:  2017-02-10

2.  Changes in health outcomes as a function of abstinence and reduction in illicit psychoactive drug use: a prospective study in primary care.

Authors:  Tae Woo Park; Debbie M Cheng; Christine A Lloyd-Travaglini; Judith Bernstein; Tibor P Palfai; Richard Saitz
Journal:  Addiction       Date:  2015-09       Impact factor: 6.526

3.  Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.

Authors:  Anne C Andorn; Barbara R Haight; Sunita Shinde; Paul J Fudala; Yue Zhao; Christian Heidbreder; Susan M Learned; Norma Lynn Fox; Vijay R Nadipelli; David Hassman; Daniel Rutrick
Journal:  J Clin Psychopharmacol       Date:  2020 May/Jun       Impact factor: 3.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.